As shown in Figure 2, MEK1 and MEK2 inhibitory activity of YQFM was associated with the kinase-disease association therapeutic area of cardiovascular disease in KinMap Data Sources. This evidence concerns the gene MAP2K2 and cardiovascular disorder.